FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2888319218> ?p ?o ?g. }

• W2888319218 endingPage "e020479" @default.
• W2888319218 startingPage "e020479" @default.
• W2888319218 abstract "Introduction Systemic sclerosis (SSc) is an autoimmune disease characterised by inflammation, fibrosis and vasculopathy. Digital ulcers (DUs) are a frequent manifestation of vasculopathy in patients with SSc. Despite recent advances in pharmacological treatments, DU still have major health and economic implications. As there is currently no proven therapeutic strategy to promote DU healing, new treatments are urgently needed. Mesenchymal stem or stromal cells (MSCs) may provide a novel therapy for DU in SSc, because of their immunomodulatory and vasculoregenerative properties. Allogeneic MSC therapy involves functionally competent MSCs from healthy donors and may be used as ‘off-the-shelf’ available treatment. This study will evaluate whether allogeneic MSC therapy is a safe and potentially efficacious treatment for DU of SSc. Methods and analysis The MANUS ( M esenchymal stromal cells for A ngiogenesis and N eovascularization in digital U lcers of S ystemic Sclerosis) Trial is a double-blind randomised placebo-controlled trial. 20 patients with SSc with refractory DU will be randomised to receive eight intramuscular injections with either placebo or 50*10 6 MSCs. The primary outcome is the toxicity of the treatment at 12 weeks after administration. Secondary outcomes include (serious) adverse events, number and time to healing of DU, pain, reported hand function, quality of life and SSc disease activity. We will also evaluate changes in nailfold capillaroscopy pattern, as well as biochemical parameters and biomarkers in peripheral blood and skin biopsies. Follow-up visits will be scheduled at 48 hours and 2, 4, 8, 12, 24 and 52 weeks post-treatment. If the results confirm safety, feasibility and potential efficacy, a large multicentre randomised controlled trial with longer follow-up will be initiated focusing on efficacy. Ethics and dissemination The study has been approved by the Dutch Central Committee on Research Concerning Human Subjects (protocol no: NL51705.000.15). The results will be disseminated through patient associations and conventional scientific channels. Trial registration number NCT03211793 ; Pre-results." @default.
• W2888319218 created "2018-08-31" @default.
• W2888319218 creator A5006079113 @default.
• W2888319218 creator A5013485196 @default.
• W2888319218 creator A5014193450 @default.
• W2888319218 creator A5015234050 @default.
• W2888319218 creator A5021597876 @default.
• W2888319218 creator A5027096828 @default.
• W2888319218 creator A5042303701 @default.
• W2888319218 creator A5044386973 @default.
• W2888319218 creator A5046171667 @default.
• W2888319218 creator A5047159099 @default.
• W2888319218 creator A5052590224 @default.
• W2888319218 creator A5070132966 @default.
• W2888319218 date "2018-08-01" @default.
• W2888319218 modified "2023-09-30" @default.
• W2888319218 title "A randomised placebo-controlled double-blind trial to assess the safety of intramuscular administration of allogeneic mesenchymal stromal cells for digital ulcers in systemic sclerosis: the MANUS Trial protocol" @default.
• W2888319218 cites W1177103533 @default.
• W2888319218 cites W137759228 @default.
• W2888319218 cites W1852715977 @default.
• W2888319218 cites W1970318981 @default.
• W2888319218 cites W1980427717 @default.
• W2888319218 cites W1984263987 @default.
• W2888319218 cites W1984544202 @default.
• W2888319218 cites W1985636547 @default.
• W2888319218 cites W1996873726 @default.
• W2888319218 cites W2004920154 @default.
• W2888319218 cites W2006178596 @default.
• W2888319218 cites W2007096562 @default.
• W2888319218 cites W2011499838 @default.
• W2888319218 cites W2014393243 @default.
• W2888319218 cites W2017407969 @default.
• W2888319218 cites W2017990928 @default.
• W2888319218 cites W2018862422 @default.
• W2888319218 cites W2019123554 @default.
• W2888319218 cites W2021191028 @default.
• W2888319218 cites W2035055610 @default.
• W2888319218 cites W2048835947 @default.
• W2888319218 cites W2049567191 @default.
• W2888319218 cites W2050600834 @default.
• W2888319218 cites W2054095354 @default.
• W2888319218 cites W2057926047 @default.
• W2888319218 cites W2063974333 @default.
• W2888319218 cites W2064596041 @default.
• W2888319218 cites W2068359838 @default.
• W2888319218 cites W2070384520 @default.
• W2888319218 cites W2070951392 @default.
• W2888319218 cites W2075083616 @default.
• W2888319218 cites W2076527346 @default.
• W2888319218 cites W2081285252 @default.
• W2888319218 cites W2084373065 @default.
• W2888319218 cites W2084463370 @default.
• W2888319218 cites W2084615847 @default.
• W2888319218 cites W2096107056 @default.
• W2888319218 cites W2097043906 @default.
• W2888319218 cites W2097087492 @default.
• W2888319218 cites W2101292483 @default.
• W2888319218 cites W2111317825 @default.
• W2888319218 cites W2113306211 @default.
• W2888319218 cites W2114857739 @default.
• W2888319218 cites W2118846800 @default.
• W2888319218 cites W2122891120 @default.
• W2888319218 cites W2126294104 @default.
• W2888319218 cites W2130371595 @default.
• W2888319218 cites W2131566159 @default.
• W2888319218 cites W2135570337 @default.
• W2888319218 cites W2138183967 @default.
• W2888319218 cites W2139971123 @default.
• W2888319218 cites W2140497630 @default.
• W2888319218 cites W2140980154 @default.
• W2888319218 cites W2145667424 @default.
• W2888319218 cites W2149186767 @default.
• W2888319218 cites W2151470207 @default.
• W2888319218 cites W2153405392 @default.
• W2888319218 cites W2154895287 @default.
• W2888319218 cites W2158780936 @default.
• W2888319218 cites W2159999899 @default.
• W2888319218 cites W2162412444 @default.
• W2888319218 cites W2163154920 @default.
• W2888319218 cites W2166250069 @default.
• W2888319218 cites W2166287136 @default.
• W2888319218 cites W2167198996 @default.
• W2888319218 cites W2168795803 @default.
• W2888319218 cites W2169459855 @default.
• W2888319218 cites W2171037207 @default.
• W2888319218 cites W2171045928 @default.
• W2888319218 cites W2228722713 @default.
• W2888319218 cites W2259139568 @default.
• W2888319218 cites W2276986098 @default.
• W2888319218 cites W2291087760 @default.
• W2888319218 cites W2314089728 @default.
• W2888319218 cites W2443555896 @default.
• W2888319218 cites W2463634052 @default.
• W2888319218 cites W2600342540 @default.
• W2888319218 cites W2884926531 @default.
• W2888319218 cites W1599144775 @default.
• W2888319218 doi "https://doi.org/10.1136/bmjopen-2017-020479" @default.
• W2888319218 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6104757" @default.

• next